As part of our ongoing aim to bring you reports of new developments, we have added a review of a recent study update on the PLUSS trial: Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants.
Study commentary is provided by study investigator Professor Brett Manley a consultant neonatologist in Melbourne, and independent commentary from Professor Keith Barrington, a neonatologist at St Justine Hospital in Montreal.
Please login below to download this issue (PDF)